Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Addex Pharma, S.A.”

37 pharma patents match "Addex Pharma, S.A." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 37
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 37 pharmaceutical patents matching "Addex Pharma, S.A." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

37 results for “Addex Pharma, S.A.” · 30,257 patents in full index Clear search

  1. US 10071095

    1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders

    Addex Pharma, S.A. · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted
  2. US 9938270

    Mono-phosphate salt of 6-fluoro-2-[4-(pyridin-2-yl)but-3-yn-1-yl]imidazo[1,2A]pyridine (dipraglurant) and polymorphs thereof as negative allosteric modulator of MGLU5 receptor

    Addex Pharma, S.A. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted
  3. US 9765091

    Tetrahydropyrazolo [3,4-b] azepine derivatives and their use as allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  4. US 9737533

    1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

    Addex Pharma, S.A. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  5. US 9266834

    1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors

    Addex Pharma, S.A. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  6. US 9226930

    1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

    Addex Pharma, S.A. · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  7. US 9132122

    1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones

    Addex Pharma, S.A. · Granted Sep 15, 2015 · Expires Sep 10, 2035

    granted
  8. US 9114138

    1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones

    Addex Pharma, S.A. · Granted Aug 25, 2015 · Expires Aug 20, 2035

    granted
  9. US 9085577

    7-aryl-1,2,4-triazolo[4,3-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

    Addex Pharma, S.A. · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted
  10. US 9073907

    Thiazoles derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Jul 7, 2015 · Expires Jul 2, 2035

    granted
  11. US 9067891

    1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mGluR2-receptors

    Addex Pharma, S.A. · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted
  12. US 8946205

    1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

    Addex Pharma, S.A. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted
  13. US 8937060

    1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of prevention of neurological and psychiatric disorders

    Addex Pharma, S.A. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted
  14. US 8906939

    3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives

    Addex Pharma, S.A. · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted
  15. US 8883826

    Alkynyl derivatives as modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Nov 11, 2014 · Expires Nov 6, 2034

    granted
  16. US 8841323

    1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors

    Addex Pharma, S.A. · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  17. US 8785486

    Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

    Addex Pharma, S.A. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  18. US 8779129

    Triazinedione derivatives as GABAB receptor modulators

    Addex Pharma, S.A. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  19. US 8748621

    1,3-disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones

    Addex Pharma, S.A. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted
  20. US 8722894

    1,3-disubstituted-4-phenyl-1H-pyridin-2-ones

    Addex Pharma, S.A. · Granted May 13, 2014 · Expires May 8, 2034

    granted
  21. US 8716480

    7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

    Addex Pharma, S.A. · Granted May 6, 2014 · Expires May 1, 2034

    granted
  22. US 8697744

    Substituted 5,6-dihydro-4H-thiazolo[4,5-E]indazoles and their use as positive allosteric modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted
  23. US 8697689

    Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted
  24. US 8691849

    3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors

    Addex Pharma, S.A. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted